Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.595
+0.2053.80%
Volume:142.80M
Turnover:793.62M
Market Cap:104.53B
PE:36.94
High:5.635
Open:5.365
Low:5.310
Close:5.390
52wk High:9.017
52wk Low:4.190
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:1.26
T/O Rate:0.76%
Dividend:0.12
Dividend Rate:2.19%
EPS(LYR):0.151
ROE:14.07%
ROA:7.51%
PB:2.75
PE(LYR):36.94
PS:2.66

Loading ...

Sino Biopharma Rebrands Global Operations Under SBP Group Identity

Reuters
·
Aug 19

China Biopharmaceuticals (01177) Mid-Year Review: Betting Big on AI and Global Expansion as Twin Growth Engines

Stock News
·
Aug 19

SBP Group H1 2026 Results: Revenue Climbs 10.6%, Innovative Drug Sales Surge 44.3%

Bulletin Express
·
Aug 19

Sino Biopharmaceutical Sets HKD 0.07 Interim Dividend, Payable 24 September 2026

Bulletin Express
·
Aug 19

Sino Biopharmaceutical H1 Revenue up 10.6% on Innovative Drug Sales

Reuters
·
Aug 19

SBP Group Profit Attributable to Owners Rises 1.4% to RMB 3.43 Billion in 1H FY26; Revenue Climbs 10.6% to RMB 19.44 Billion

Reuters
·
Aug 19

Sino Biopharm Declares 2026 Interim Dividend of HKD 0.07 a Share

Reuters
·
Aug 19

Sino Biopharmaceutical H1 Revenue RMB 1,944 Million

THOMSON REUTERS
·
Aug 19

Sino Biopharmaceutical - Interim Dividend of Hk7 CENTS\nPER Share

THOMSON REUTERS
·
Aug 19

Ping an Healthcare Names Yougang Zhu Chairman in Board Reshuffle

Reuters
·
Aug 18

Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 14

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 12

Earning Preview: SBP GROUP Q2 revenue is expected to increase, and institutional views are cautiously positive

Earnings Agent
·
Aug 12

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 10

Movement Alert|SBP GROUP Rises 3.83% in Regular Trading, Beimosubai Plus Anlotinib Lung Squamous Cell Carcinoma Indication Approved

Market Focus
·
Aug 10

SK Hynix Greenlights 54 Trillion Won Chip Expansion; Beijing Slashes Homebuying Tax Threshold for Non-Local Families to One Year

Stock News
·
Aug 10

Sino Biopharmaceutical Says NMPA Approves Benmelstobart

Reuters
·
Aug 08

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

MT Newswires Live
·
Aug 07

SBP Group Receives Approval for New Lung Cancer Treatment Combination

Stock News
·
Aug 07

Sino Biopharma Wins China NMPA Approval for First-Line Squamous NSCLC Combo Therapy

Reuters
·
Aug 07